Method of screening for the presence of a genetic defect associated with deep venous thrombosis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8067209
APP PUB NO 20090269738A1
SERIAL NO

11887495

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A. The genetic marker comprises a set of one, two, three or four mutations in the nucleic acid material encoding fibrinogen γ, the mutations being selected from the group consisting of 129A/T (rs2066854), 7874G/A (rs20668β1), 9615′C/T (rs2066864) and 10034C/T (rs2066865).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOMERIEUX B V5280 AB BOXTEL

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bertina, Rogier Maria Leiden, NL 8 25
Henrica, de Visser-van Soest Maria Catharina Leiderdorp, NL 1 0
Rosendaal, Frits R Wassenaar, NL 15 58
Uitte, de Willige Shirley Leeds, GB 1 0
Vos, Hans Luuk Bodegraven, NL 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation